In the current study, we analyzed the expression profiles of VDR and PTX3 mRNA in CCs isolated from GV, MI and MII stage COCs of PCOS and non-PCOS control patients under the GnRH antagonist protocol. This evidence concerns the gene PTX3 and polycystic ovary syndrome.